BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21159009)

  • 1. Deposition of hyperphosphorylated tau in cerebellum of PS1 E280A Alzheimer's disease.
    Sepulveda-Falla D; Matschke J; Bernreuther C; Hagel C; Puig B; Villegas A; Garcia G; Zea J; Gomez-Mancilla B; Ferrer I; Lopera F; Glatzel M
    Brain Pathol; 2011 Jul; 21(4):452-63. PubMed ID: 21159009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial Alzheimer's disease-associated presenilin-1 alters cerebellar activity and calcium homeostasis.
    Sepulveda-Falla D; Barrera-Ocampo A; Hagel C; Korwitz A; Vinueza-Veloz MF; Zhou K; Schonewille M; Zhou H; Velazquez-Perez L; Rodriguez-Labrada R; Villegas A; Ferrer I; Lopera F; Langer T; De Zeeuw CI; Glatzel M
    J Clin Invest; 2014 Apr; 124(4):1552-67. PubMed ID: 24569455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology.
    Lemere CA; Lopera F; Kosik KS; Lendon CL; Ossa J; Saido TC; Yamaguchi H; Ruiz A; Martinez A; Madrigal L; Hincapie L; Arango JC; Anthony DC; Koo EH; Goate AM; Selkoe DJ; Arango JC
    Nat Med; 1996 Oct; 2(10):1146-50. PubMed ID: 8837617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased Deposition of Beta-Amyloid 1-38 and Increased Deposition of Beta-Amyloid 1-42 in Brain Tissue of Presenilin-1 E280A Familial Alzheimer's Disease Patients.
    Dinkel F; Trujillo-Rodriguez D; Villegas A; Streffer J; Mercken M; Lopera F; Glatzel M; Sepulveda-Falla D
    Front Aging Neurosci; 2020; 12():220. PubMed ID: 32848702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein markers for Alzheimer disease in the frontal cortex and cerebellum.
    Verdile G; Gnjec A; Miklossy J; Fonte J; Veurink G; Bates K; Kakulas B; Mehta PD; Milward EA; Tan N; Lareu R; Lim D; Dharmarajan A; Martins RN
    Neurology; 2004 Oct; 63(8):1385-92. PubMed ID: 15505153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multifactorial model of pathology for age of onset heterogeneity in familial Alzheimer's disease.
    Sepulveda-Falla D; Chavez-Gutierrez L; Portelius E; Vélez JI; Dujardin S; Barrera-Ocampo A; Dinkel F; Hagel C; Puig B; Mastronardi C; Lopera F; Hyman BT; Blennow K; Arcos-Burgos M; de Strooper B; Glatzel M
    Acta Neuropathol; 2021 Feb; 141(2):217-233. PubMed ID: 33319314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors.
    Gómez-Isla T; Growdon WB; McNamara MJ; Nochlin D; Bird TD; Arango JC; Lopera F; Kosik KS; Lantos PL; Cairns NJ; Hyman BT
    Brain; 1999 Sep; 122 ( Pt 9)():1709-19. PubMed ID: 10468510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic profile of early-onset familial Alzheimer's disease caused by presenilin-1 E280A mutation.
    Sepulveda-Falla D; Glatzel M; Lopera F
    J Alzheimers Dis; 2012; 32(1):1-12. PubMed ID: 22766738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel PSEN1 K311R Mutation Discovered in Chinese Families with Late-Onset Alzheimer's Disease Affects Amyloid-β Production and Tau Phosphorylation.
    Dong J; Qin W; Wei C; Tang Y; Wang Q; Jia J
    J Alzheimers Dis; 2017; 57(2):613-623. PubMed ID: 28269784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced accumulation of phosphorylated alpha-synuclein and elevated beta-amyloid 42/40 ratio caused by expression of the presenilin-1 deltaT440 mutant associated with familial Lewy body disease and variant Alzheimer's disease.
    Kaneko H; Kakita A; Kasuga K; Nozaki H; Ishikawa A; Miyashita A; Kuwano R; Ito G; Iwatsubo T; Takahashi H; Nishizawa M; Onodera O; Sisodia SS; Ikeuchi T
    J Neurosci; 2007 Nov; 27(48):13092-7. PubMed ID: 18045903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sildenafil Reverses the Neuropathological Alzheimer's Disease Phenotype in Cholinergic-Like Neurons Carrying the Presenilin 1 E280A Mutation.
    Giraldo-Berrio D; Jimenez-Del-Rio M; Velez-Pardo C
    J Alzheimers Dis; 2024; 99(2):639-656. PubMed ID: 38728184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid levels of phosphorylated tau and Aβ1-38/Aβ1-40/Aβ1-42 in Alzheimer's disease with PS1 mutations.
    Ikeda M; Yonemura K; Kakuda S; Tashiro Y; Fujita Y; Takai E; Hashimoto Y; Makioka K; Furuta N; Ishiguro K; Maruki R; Yoshida J; Miyaguchi O; Tsukie T; Kuwano R; Yamazaki T; Yamaguchi H; Amari M; Takatama M; Harigaya Y; Okamoto K
    Amyloid; 2013 Jun; 20(2):107-12. PubMed ID: 23638752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes.
    Kurt MA; Davies DC; Kidd M; Duff K; Howlett DR
    Neurobiol Dis; 2003 Oct; 14(1):89-97. PubMed ID: 13678670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
    Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
    JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heavy Tau Burden with Subtle Amyloid β Accumulation in the Cerebral Cortex and Cerebellum in a Case of Familial Alzheimer's Disease with APP Osaka Mutation.
    Shimada H; Minatani S; Takeuchi J; Takeda A; Kawabe J; Wada Y; Mawatari A; Watanabe Y; Shimada H; Higuchi M; Suhara T; Tomiyama T; Itoh Y
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32580499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological correlations and cholinesterase expression in early-onset familial Alzheimer's disease with the presenilin 1 mutation, Leu235Pro.
    Cash MK; Rockwood K; Fisk JD; Darvesh S
    Neurobiol Aging; 2021 Jul; 103():31-41. PubMed ID: 33789210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer's Disease.
    Narayanan SE; Sekhar N; Rajamma RG; Marathakam A; Al Mamun A; Uddin MS; Mathew B
    Curr Protein Pept Sci; 2020; 21(12):1164-1173. PubMed ID: 32957903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau load is associated with apolipoprotein E genotype and the amount of amyloid beta protein, Abeta40, in sporadic and familial Alzheimer's disease.
    Thaker U; McDonagh AM; Iwatsubo T; Lendon CL; Pickering-Brown SM; Mann DM
    Neuropathol Appl Neurobiol; 2003 Feb; 29(1):35-44. PubMed ID: 12581338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathology and biochemistry of early onset familial Alzheimer's disease caused by presenilin-1 missense mutation Thr116Asn.
    Sutovsky S; Smolek T; Turcani P; Petrovic R; Brandoburova P; Jadhav S; Novak P; Attems J; Zilka N
    J Neural Transm (Vienna); 2018 Jun; 125(6):965-976. PubMed ID: 29404783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.